Dr. Sarah Ali
Royal Free Hospital, London
Dr Sarah N Ali BM BCh (Oxon), BSc (Hons), MRCP, FRSA
Dr Sarah Ali is a Consultant Diabetologist at the Royal Free Hospital, London since 2016. She is the Clinical Lead for the Barnet Diabetes Community Service and the Royal Free Hospital Diabetes Antenatal Service.
She has served as the committee Consultant Diabetologist for the National Institute for Health and Care Excellence (NICE) Diabetes guidelines update for type 1, type 2 and diabetic nephropathy (2019-2023). She has worked on a number of diabetes research and national projects, including co-authoring a NHS England project on the best delivery of Diabetes in the Primary Care Networks. She is additionally Trustee for the South Asian Health Foundation, UK and Trustee for Diabetes UK, where her main focus is on ensuring equity of healthcare.
Her specialist interests include diabetes in ethnic minorities (esp South Asians), health inequalities in the BAME communities, the delivery of high-quality Community diabetes care, diabetes in pregnancy and diabetes in Ramadan, with publications in all of these fields.
She has been a Principal Investigator at one of three UK sites undertaking research into the risk stratification of patients with Type 2 Diabetes using multi-organ quantitative MRI scans sponsored by Innovate UK and Perspectum Diagnostics Ltd, and the RFH PI for EXTOD-Immune study. She is currently the Principal Investigator for the SMART study (Treg-sparing co-stimulation blockade: testing a novel method for monitoring an immunosuppression strategy in people with Type 1 diabetes) sponsored by Cardiff University. It is funded by Steve Morgan Foundation through Grand Challenge award with Breakthrough T1D and Diabetes UK.
Dr Sarah N Ali read Medicine at the University of Oxford. She underwent her specialist training in Diabetes and Endocrinology on the North West London Rotation, including Imperial College London where she was a Clinical Research Fellow from 2011 – 2012; her research interest at that time was in obesity and eating behaviours.
In addition, Sarah is an artist and a Fellow of the Royal Society of Arts (FRSA) with a particular interest in abstract medical art and has collaborated on a number of projects using art to raise health awareness.
Dr Sarah Ali is a Consultant Diabetologist at the Royal Free Hospital, London since 2016. She is the Clinical Lead for the Barnet Diabetes Community Service and the Royal Free Hospital Diabetes Antenatal Service.
She has served as the committee Consultant Diabetologist for the National Institute for Health and Care Excellence (NICE) Diabetes guidelines update for type 1, type 2 and diabetic nephropathy (2019-2023). She has worked on a number of diabetes research and national projects, including co-authoring a NHS England project on the best delivery of Diabetes in the Primary Care Networks. She is additionally Trustee for the South Asian Health Foundation, UK and Trustee for Diabetes UK, where her main focus is on ensuring equity of healthcare.
Her specialist interests include diabetes in ethnic minorities (esp South Asians), health inequalities in the BAME communities, the delivery of high-quality Community diabetes care, diabetes in pregnancy and diabetes in Ramadan, with publications in all of these fields.
She has been a Principal Investigator at one of three UK sites undertaking research into the risk stratification of patients with Type 2 Diabetes using multi-organ quantitative MRI scans sponsored by Innovate UK and Perspectum Diagnostics Ltd, and the RFH PI for EXTOD-Immune study. She is currently the Principal Investigator for the SMART study (Treg-sparing co-stimulation blockade: testing a novel method for monitoring an immunosuppression strategy in people with Type 1 diabetes) sponsored by Cardiff University. It is funded by Steve Morgan Foundation through Grand Challenge award with Breakthrough T1D and Diabetes UK.
Dr Sarah N Ali read Medicine at the University of Oxford. She underwent her specialist training in Diabetes and Endocrinology on the North West London Rotation, including Imperial College London where she was a Clinical Research Fellow from 2011 – 2012; her research interest at that time was in obesity and eating behaviours.
In addition, Sarah is an artist and a Fellow of the Royal Society of Arts (FRSA) with a particular interest in abstract medical art and has collaborated on a number of projects using art to raise health awareness.
